| Serial Number | 79377648 |
| Word Mark | HEALOME THERAPEUTICS |
| Filing Date | Monday, February 27, 2023 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Tuesday, July 9, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of two intersecting ovals made up of small aqua, black, and navy circles with the wording "HEALOME THERAPEUTICS" located below in black. White in the mark is background and not a feature of the mark. |
| Goods and Services | Pharmaceutical preparations and substances; pharmaceutical preparations, substances and treatment for ocular diseases and conditions; pharmaceutical preparations, substances and treatment for ocular diseases, ocular surface diseases and dry eye disease; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations, substances and treatment for dermal diseases and conditions; pharmaceutical preparations, substances and treatment for scar prevention, wound healing, medical aesthetics and orthopaedic conditions; therapeutic preparations and substances for the treatment of ocular diseases, ocular conditions, ocular surface diseases and dry eye disease; gels; therapeutic gels; gel and liquid drops, sprays, films, suspensions, and substances for the treatment of ocular diseases and conditions; gels, suspensions, and liquids for the treatment of ocular diseases and conditions; gels, suspensions, liquids and lubricants for the treatment of eye conditions and diseases; tear film substitutes for the treatment of ocular conditions; tear film substitutes for the treatment of eye conditions and diseases; gels, suspensions, liquids and lubricants for the treatment of eye conditions, namely, glaucoma, cataracts, amblyopia, age-related macular degeneration and diabetes-related retinopathy; gels, suspensions, and liquids for medical and therapeutic use; eye drops; eye ointment; eye-washes; eye lotions for medical use; lubricating eye drops; liquid for the treatment of ocular diseases and conditions; ocular lubricants; tear film substitutes; tear substitutes for ocular diseases and conditions; tear film substitutes for ocular diseases and conditions |
| Indication of Colors claimed | The color(s) aqua, black and navy is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Scientific and technological services and research and design relating thereto; industrial analysis and research services; product research and development services; scientific and technological services and research services relating thereto; scientific research services for medical, biomedical and therapeutic purposes; medical and bioscience research services; biomedical research services; technical surveying and exploration services; research and development services relating to ocular diseases, treatment and conditions; research and development services relating to orthopaedics; research and development services relating to dermatology; research and development services relating to dermal applications, such as scar prevention, wound healing, medical aesthetics; research and development services relating to the treatment of diseases and conditions; research services relating to the treatment of eye diseases and conditions; therapeutic research services; advisory, consultancy and information services relating to all the aforesaid |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 1, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 1, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Healome Therapeutics Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Thursday, August 31, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, September 1, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 5, 2023 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, October 25, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, October 25, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, October 25, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, October 25, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, October 25, 2023 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, October 25, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, November 28, 2023 | ASSIGNED TO EXAMINER |
| Monday, December 4, 2023 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 5, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, December 13, 2023 | REFUSAL PROCESSED BY MPU |
| Wednesday, December 13, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, January 3, 2024 | REFUSAL PROCESSED BY IB |
| Tuesday, June 4, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 4, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 4, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 9, 2024 | FINAL REFUSAL E-MAILED |
| Tuesday, July 9, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, July 9, 2024 | FINAL REFUSAL WRITTEN |